BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36422933)

  • 1. Establishing and Integrating a Female Genital Schistosomiasis Control Programme into the Existing Health Care System.
    Nemungadi TG; Furumele TE; Gugerty MK; Djirmay AG; Naidoo S; Kjetland EF
    Trop Med Infect Dis; 2022 Nov; 7(11):. PubMed ID: 36422933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing a silent and neglected scourge in sexual and reproductive health in Sub-Saharan Africa by development of training competencies to improve prevention, diagnosis, and treatment of female genital schistosomiasis (FGS) for health workers.
    Jacobson J; Pantelias A; Williamson M; Kjetland EF; Krentel A; Gyapong M; Mbabazi PS; Djirmay AG
    Reprod Health; 2022 Jan; 19(1):20. PubMed ID: 35073965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A major hurdle in the elimination of urogenital schistosomiasis revealed: Identifying key gaps in knowledge and understanding of female genital schistosomiasis within communities and local health workers.
    Kukula VA; MacPherson EE; Tsey IH; Stothard JR; Theobald S; Gyapong M
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007207. PubMed ID: 30897093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association Between Female Genital Schistosomiasis and Other Infections of the Lower Genital Tract in Adolescent Girls and Young Women: A Cross-Sectional Study in South Africa.
    Shukla JD; Kleppa E; Holmen S; Ndhlovu PD; Mtshali A; Sebitloane M; Vennervald BJ; Gundersen SG; Taylor M; Kjetland EF
    J Low Genit Tract Dis; 2023 Jul; 27(3):291-296. PubMed ID: 37379442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women.
    Ndeffo Mbah ML; Poolman EM; Atkins KE; Orenstein EW; Meyers LA; Townsend JP; Galvani AP
    PLoS Negl Trop Dis; 2013; 7(8):e2346. PubMed ID: 23936578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping Schistosoma haematobium for Novel Interventions against Female Genital Schistosomiasis and Associated HIV Risk in KwaZulu-Natal, South Africa.
    Livingston M; Pillay P; Zulu SG; Sandvik L; Kvalsvig JD; Gagai S; Galappaththi-Arachchige HN; Kleppa E; Ndhlovu P; Vennervald B; Gundersen SG; Taylor M; Kjetland EF
    Am J Trop Med Hyg; 2021 May; 104(6):2055-2064. PubMed ID: 33939629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervicovaginal Immune Activation in Zambian Women With Female Genital Schistosomiasis.
    Sturt AS; Webb EL; Patterson C; Phiri CR; Mweene T; Kjetland EF; Mudenda M; Mapani J; Mutengo MM; Chipeta J; van Dam GJ; Corstjens PLAM; Ayles H; Hayes RJ; Hansingo I; Cools P; van Lieshout L; Helmby H; McComsey GA; Francis SC; Bustinduy AL
    Front Immunol; 2021; 12():620657. PubMed ID: 33737927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urogenital schistosomiasis (UGS) and female genital schistosomiasis (FGS) in Cameroon: an observational assessment of key reproductive health determinants of girls and women in the Matta Health Area.
    Makia CM; Fesuh NB; Amabo EN; Gamba VA; Oluwole AS; Stothard R
    BMJ Open; 2023 Feb; 13(2):e063392. PubMed ID: 36787976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to bring female genital schistosomiasis out of neglect.
    Lamberti O; Bozzani F; Kiyoshi K; Bustinduy AL
    Br Med Bull; 2024 Mar; 149(1):45-59. PubMed ID: 38220571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities.
    Ndeffo Mbah ML; Gilbert JA; Galvani AP
    Epidemics; 2014 Jun; 7():22-7. PubMed ID: 24928666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quality improvement approach in co-developing a primary healthcare package for raising awareness and managing female genital schistosomiasis in Nigeria and Liberia.
    Oluwole AS; Bettee AK; Nganda MM; Piotrowski HL; Fapohunda VO; Adejobi JB; Soneye IY; Kafil-Emiola MA; Soyinka FO; Nebe OJ; Ekpo UF; Kollie KK; Isiyaku S; Thomson R; Dean L; Ozano K;
    Int Health; 2023 Mar; 15(Suppl 1):i30-i42. PubMed ID: 36960805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating the diagnosis and management of female genital schistosomiasis in primary healthcare in Liberia: a mixed methods pilot study.
    Nganda M; Bettee AK; Kollie K; Nallo GE; Juabeh M; Wright A; Thomson R; Dean L
    Int Health; 2023 Mar; 15(Suppl 1):i43-i51. PubMed ID: 36960802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female Genital Schistosomiasis (FGS) in Cameroon: A formative epidemiological and socioeconomic investigation in eleven rural fishing communities.
    Masong MC; Wepnje GB; Marlene NT; Gamba V; Mengue MT; Kouokam E; Stothard JR; Ekobo ALS
    PLOS Glob Public Health; 2021; 1(10):e0000007. PubMed ID: 36962084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability and feasibility of genital self-sampling for the diagnosis of female genital schistosomiasis: a cross-sectional study in Zambia.
    Rutty Phiri C; Sturt AS; Webb EL; Chola N; Hayes R; Shanaube K; Ayles H; Hansingo I; Bustinduy AL;
    Wellcome Open Res; 2020; 5():61. PubMed ID: 33154978
    [No Abstract]   [Full Text] [Related]  

  • 15. The parasitology of female genital schistosomiasis.
    Orish VN; Morhe EKS; Azanu W; Alhassan RK; Gyapong M
    Curr Res Parasitol Vector Borne Dis; 2022; 2():100093. PubMed ID: 35719849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of female genital schistosomiasis into HIV/sexual and reproductive health and rights and neglected tropical diseases programmes and services: a scoping review.
    Umbelino-Walker I; Wong F; Cassolato M; Pantelias A; Jacobson J; Kalume C
    Sex Reprod Health Matters; 2023 Dec; 31(1):2262882. PubMed ID: 37850814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the Response of Health Systems to Female Genital Schistosomiasis in Endemic Countries through a Gender-Sensitive Human Rights-Based Framework.
    Vlassoff C; Arogundade K; Patel K; Jacobson J; Gyapong M; Krentel A
    Diseases; 2022 Dec; 10(4):. PubMed ID: 36547211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The colposcopic atlas of schistosomiasis in the lower female genital tract based on studies in Malawi, Zimbabwe, Madagascar and South Africa.
    Norseth HM; Ndhlovu PD; Kleppa E; Randrianasolo BS; Jourdan PM; Roald B; Holmen SD; Gundersen SG; Bagratee J; Onsrud M; Kjetland EF
    PLoS Negl Trop Dis; 2014; 8(11):e3229. PubMed ID: 25412334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of lower genital tract lesions among women of reproductive age infected with Schistosoma mansoni: A cross-sectional study using a colposcope in Western Kenya.
    Sang HC; Mwinzi PNM; Odiere MR; Onkanga I; Rawago F; Pillay P; Kjetland EF
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010473. PubMed ID: 35802746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human rights as a framework for eliminating female genital schistosomiasis.
    Williams CR; Seunik M; Meier BM
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010165. PubMed ID: 35239651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.